Lupin Pharma Canada Ltd
Jan Kowalczewski is a seasoned professional in the pharmaceutical and rehabilitation sectors, currently serving in Medical Strategy at Lupin Pharma Canada Ltd since February 2015. In this role, Jan contributes to the launch of a new indication for the flagship product and works on expanding the pipeline of innovative products. Previously, Jan held the position of VP Clinical at Rehabtronics, focusing on a clinically validated tele-rehabilitation platform, and served as CTO at Angeltear Solutions Inc. From 2004 to 2012, Jan worked as a Medical Illustrator while pursuing a PhD in Neuroscience from the University of Alberta, where earlier studies culminated in a BSc in Physiology.
This person is not in any teams
Lupin Pharma Canada Ltd
Building on its parent company's solid reputation, Lupin Pharma Canada Limited is committed to strengthening its branded product portfolio with the launch of additional medicines developed from its own research and manufacturing process, as well as through strategic brand acquisitions and licensing. Lupin Pharma Canada Ltd also entered the generic pharmaceutical marketplace in 2016 in the hormone therapeutic area.